NCT06133075View on ClinicalTrials.gov

Using Mirabegron to Increase BP in Patients With POTS

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

May 20, 2025

Study Completion Date

July 25, 2025

Conditions
Postural Orthostatic Tachycardia SyndromeChronic Orthostatic IntoleranceSyncope
Interventions
DRUG

Mirabegron 50 MG

10 patients will receive drug for 8 weeks

DRUG

Mirabegron 25 MG

10 patients will receive drug for 8 weeks

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT06133075 - Using Mirabegron to Increase BP in Patients With POTS | Biotech Hunter | Biotech Hunter